Active Biotech AB (publ) (STO:ACTI)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0870
+0.0010 (1.16%)
Apr 25, 2025, 5:29 PM CET
-64.96%
Market Cap 105.79M
Revenue (ttm) n/a
Net Income (ttm) -39.40M
Shares Out 1.23B
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,122,565
Average Volume 7,178,220
Open 0.0872
Previous Close 0.0860
Day's Range 0.0810 - 0.0937
52-Week Range 0.0630 - 0.6290
Beta 0.73
RSI 52.06
Earnings Date May 8, 2025

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that has completed phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company was incorporated in 198... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1983
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol ACTI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.